Campbell Belman Releases Comprehensive Report for Pharmaceutical Marketers to Maximize Their Bottom Line

NEW YORK, N.Y. – Feb. 20 (SEND2PRESS NEWSWIRE) — Campbell Belman’s mission is to remove the uncertainty about marketing return-on-investment (ROI) for pharmaceutical companies; a new comprehensive report releases proven approaches for real and measurable results. The pharmaceutical environment is turbulent, and what used to work to create an industry wide growth of 20 percent, no longer does.